INNOVIVA, INC. Research and Development Expense
INNOVIVA, INC. (INVA) reported Research and Development Expense of $5.19 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-05
- INNOVIVA, INC. research and development expense for the quarter ending 2026-06-30 was $5.19M, a 34.99% decline year-over-year.
- INNOVIVA, INC. research and development expense for the quarter ending 2026-03-31 was $5.24M, a 19.22% increase year-over-year.
- INNOVIVA, INC. research and development expense for the quarter ending 2025-12-31 was $4.55M, a 24.28% increase year-over-year.
- INNOVIVA, INC. research and development expense for the quarter ending 2025-09-30 was $13.67M, a 284.96% increase year-over-year.
- INNOVIVA, INC. research and development expense for fiscal 2025 was $30.60M, a 124.14% increase from fiscal 2024.
- INNOVIVA, INC. research and development expense for fiscal 2024 was $13.65M, a 59.75% decline from fiscal 2023.
- INNOVIVA, INC. research and development expense for fiscal 2023 was $33.92M, a 18.13% decline from fiscal 2022.
- INNOVIVA, INC. research and development expense for fiscal 2022 was $41.43M, a 7093.06% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $5.19M 10-Q · filed 2026-08-05 | $10.43M 10-Q · filed 2026-08-05 | $14.99M derived: sum of 3 quarters · filed 2026-08-05 | $28.66M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | $5.24M 10-Q · filed 2026-05-06 | $9.80M derived: sum of 2 quarters · filed 2026-05-06 | $23.47M derived: sum of 3 quarters · filed 2026-05-06 | $31.45M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $4.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $18.23M derived: sum of 2 quarters · filed 2026-02-25 | $26.21M derived: sum of 3 quarters · filed 2026-08-05 | $30.60M 10-K · filed 2026-02-25 | ||||
| 2025-09-30 | $13.67M 10-Q · filed 2025-11-05 | $21.65M derived: sum of 2 quarters · filed 2026-08-05 | $26.05M 10-Q · filed 2025-11-05 | $29.71M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $7.98M 10-Q · filed 2026-08-05 | $12.38M 10-Q · filed 2026-08-05 | $16.04M derived: sum of 3 quarters · filed 2026-08-05 | $19.59M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | $4.40M 10-Q · filed 2026-05-06 | $8.06M derived: sum of 2 quarters · filed 2026-05-06 | $11.61M derived: sum of 3 quarters · filed 2026-05-06 | $14.17M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | $3.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $7.22M derived: sum of 2 quarters · filed 2026-02-25 | $9.78M derived: sum of 3 quarters · filed 2026-02-25 | $13.65M 10-K · filed 2026-02-25 | ||||
| 2024-09-30 | $3.55M 10-Q · filed 2025-11-05 | $6.11M derived: sum of 2 quarters · filed 2025-11-05 | $9.99M 10-Q · filed 2025-11-05 | $12.35M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-06-30 | $2.56M 10-Q · filed 2025-08-06 | $6.44M 10-Q · filed 2025-08-06 | $8.79M derived: sum of 3 quarters · filed 2026-02-25 | $12.78M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-03-31 | $3.88M 10-Q · filed 2025-05-07 | $6.23M derived: sum of 2 quarters · filed 2026-02-25 | $10.22M derived: sum of 3 quarters · filed 2026-02-25 | $25.21M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2023-12-31 | $2.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $6.34M derived: sum of 2 quarters · filed 2026-02-25 | $21.33M derived: sum of 3 quarters · filed 2026-02-25 | $33.92M 10-K · filed 2026-02-25 | ||||
| 2023-09-30 | $3.99M 10-Q · filed 2024-11-06 | $18.98M derived: sum of 2 quarters · filed 2024-11-06 | $31.57M 10-Q · filed 2024-11-06 | $41.55M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2023-06-30 | $14.99M 10-Q · filed 2024-07-31 | $27.58M 10-Q · filed 2024-07-31 | $37.56M derived: sum of 3 quarters · filed 2025-02-26 | $49.29M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2023-03-31 | $12.59M 10-Q · filed 2024-05-08 | $22.57M derived: sum of 2 quarters · filed 2025-02-26 | $34.30M derived: sum of 3 quarters · filed 2025-02-26 | $48.18M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2022-12-31 | $9.98M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $21.71M derived: sum of 2 quarters · filed 2025-02-26 | $35.59M derived: sum of 3 quarters · filed 2025-02-26 | $41.43M 10-K · filed 2025-02-26 | ||||
| 2022-09-30 | $11.72M 10-Q · filed 2023-11-01 | $25.61M derived: sum of 2 quarters · filed 2023-11-01 | $31.45M 10-Q · filed 2023-11-01 | $31.49M derived: sum of 4 quarters · filed 2024-03-05 | ||||
| 2022-06-30 | $13.88M 10-Q · filed 2023-08-02 | $19.72M 10-Q · filed 2023-08-02 | $19.76M derived: sum of 3 quarters · filed 2024-03-05 | $20.21M derived: sum of 4 quarters · filed 2024-03-05 | ||||
| 2022-03-31 | $5.84M 10-Q · filed 2023-05-09 | $5.88M derived: sum of 2 quarters · filed 2024-03-05 | $6.33M derived: sum of 3 quarters · filed 2024-03-05 | $6.37M derived: sum of 4 quarters · filed 2024-03-05 | ||||
| 2021-12-31 | $40.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-03-05 | $489.00K derived: sum of 2 quarters · filed 2024-03-05 | $527.00K derived: sum of 3 quarters · filed 2024-03-05 | $576.00K 10-K/A · filed 2024-03-05 | ||||
| 2021-09-30 | $449.00K 10-Q · filed 2022-11-09 | $487.00K derived: sum of 2 quarters · filed 2022-11-09 | $536.00K 10-Q · filed 2022-11-09 | $755.00K derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-06-30 | $38.00K 10-Q · filed 2022-07-27 | $87.00K 10-Q · filed 2022-07-27 | $306.00K derived: sum of 3 quarters · filed 2023-02-28 | $1.32M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-03-31 | $49.00K 10-Q · filed 2022-05-05 | $268.00K derived: sum of 2 quarters · filed 2023-02-28 | $1.28M derived: sum of 3 quarters · filed 2023-02-28 | $1.84M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | $219.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $1.23M derived: sum of 2 quarters · filed 2023-02-28 | $1.79M derived: sum of 3 quarters · filed 2023-02-28 | $1.79M 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | $1.01M 10-Q · filed 2021-10-27 | $1.57M derived: sum of 2 quarters · filed 2021-10-27 | $1.57M 10-Q · filed 2021-10-27 | $1.57M derived: sum of 4 quarters · filed 2022-03-17 | ||||
| 2020-06-30 | $559.00K 10-Q · filed 2021-07-29 | $559.00K 10-Q · filed 2021-07-29 | $559.00K derived: sum of 3 quarters · filed 2022-03-17 | $559.00K derived: sum of 4 quarters · filed 2022-03-17 | ||||
| 2020-03-31 | $0.00 10-Q · filed 2021-04-28 | $0.00 derived: sum of 2 quarters · filed 2022-03-17 | $0.00 derived: sum of 3 quarters · filed 2022-03-17 | $0.00 derived: sum of 4 quarters · filed 2022-03-17 | ||||
| 2019-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-03-17 | $0.00 derived: sum of 2 quarters · filed 2022-03-17 | $0.00 derived: sum of 3 quarters · filed 2022-03-17 | $0.00 10-K/A · filed 2022-03-17 | ||||
| 2019-09-30 | $0.00 10-Q · filed 2020-10-28 | $0.00 derived: sum of 2 quarters · filed 2020-10-28 | $0.00 10-Q · filed 2020-10-28 | |||||
| 2019-06-30 | $0.00 10-Q · filed 2020-07-29 | $0.00 10-Q · filed 2020-07-29 | ||||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $0.00 derived: sum of 2 quarters · filed 2021-02-25 | $0.00 derived: sum of 3 quarters · filed 2021-02-25 | $0.00 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | $0.00 10-Q · filed 2018-10-31 | $0.00 derived: sum of 2 quarters · filed 2018-10-31 | $0.00 10-Q · filed 2018-10-31 | $342.00K derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-06-30 | $0.00 10-Q · filed 2018-07-26 | $0.00 10-Q · filed 2018-07-26 | $342.00K derived: sum of 3 quarters · filed 2020-02-19 | $653.00K derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-03-31 | $0.00 10-Q · filed 2018-05-04 | $342.00K derived: sum of 2 quarters · filed 2020-02-19 | $653.00K derived: sum of 3 quarters · filed 2020-02-19 | $1.00M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2017-12-31 | $342.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $653.00K derived: sum of 2 quarters · filed 2020-02-19 | $1.00M derived: sum of 3 quarters · filed 2020-02-19 | $1.35M 10-K · filed 2020-02-19 | ||||
| 2017-09-30 | $311.00K 10-Q · filed 2018-10-31 | $659.00K derived: sum of 2 quarters · filed 2018-10-31 | $1.01M 10-Q · filed 2018-10-31 | $1.36M derived: sum of 4 quarters · filed 2019-02-19 | ||||
| 2017-06-30 | $348.00K 10-Q · filed 2018-07-26 | $702.00K 10-Q · filed 2018-07-26 | $1.05M derived: sum of 3 quarters · filed 2019-02-19 | $1.33M derived: sum of 4 quarters · filed 2019-02-19 | ||||
| 2017-03-31 | $354.00K 10-Q · filed 2018-05-04 | $699.00K derived: sum of 2 quarters · filed 2019-02-19 | $985.00K derived: sum of 3 quarters · filed 2019-02-19 | $1.35M derived: sum of 4 quarters · filed 2019-02-19 | ||||
| 2016-12-31 | $345.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | $631.00K derived: sum of 2 quarters · filed 2019-02-19 | $1.00M derived: sum of 3 quarters · filed 2019-02-19 | $1.39M 10-K · filed 2019-02-19 | ||||
| 2016-09-30 | $286.00K 10-Q · filed 2017-11-03 | $656.00K derived: sum of 2 quarters · filed 2017-11-03 | $1.05M 10-Q · filed 2017-11-03 | $1.77M derived: sum of 4 quarters · filed 2018-02-23 | ||||
| 2016-06-30 | $370.00K 10-Q · filed 2017-08-08 | $762.00K 10-Q · filed 2017-08-08 | $1.48M derived: sum of 3 quarters · filed 2018-02-23 | $2.03M derived: sum of 4 quarters · filed 2018-02-23 | ||||
| 2016-03-31 | $392.00K 10-Q · filed 2017-05-05 | $1.11M derived: sum of 2 quarters · filed 2018-02-23 | $1.66M derived: sum of 3 quarters · filed 2018-02-23 | $2.30M derived: sum of 4 quarters · filed 2018-02-23 | ||||
| 2015-12-31 | $722.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $1.27M derived: sum of 2 quarters · filed 2018-02-23 | $1.91M derived: sum of 3 quarters · filed 2018-02-23 | $2.62M 10-K · filed 2018-02-23 | ||||
| 2015-09-30 | $547.00K 10-Q · filed 2016-11-03 | $1.19M derived: sum of 2 quarters · filed 2016-11-03 | $1.90M 10-Q · filed 2016-11-03 | $2.67M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-06-30 | $638.00K 10-Q · filed 2016-08-04 | $1.35M 10-Q · filed 2016-08-04 | $2.13M derived: sum of 3 quarters · filed 2017-02-28 | $4.04M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-03-31 | $712.00K 10-Q · filed 2016-05-05 | $1.49M derived: sum of 2 quarters · filed 2017-02-28 | $3.40M derived: sum of 3 quarters · filed 2017-02-28 | $5.52M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2014-12-31 | $777.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $2.69M derived: sum of 2 quarters · filed 2017-02-28 | $4.81M derived: sum of 3 quarters · filed 2017-02-28 | $7.50M 10-K · filed 2017-02-28 | ||||
| 2014-09-30 | $1.91M 10-Q · filed 2015-11-05 | $4.03M derived: sum of 2 quarters · filed 2015-11-05 | $6.72M 10-Q · filed 2015-11-05 | $9.20M derived: sum of 4 quarters · filed 2016-02-24 | ||||
| 2014-06-30 | $2.13M 10-Q · filed 2015-08-06 | $4.81M 10-Q · filed 2015-08-06 | $7.29M derived: sum of 3 quarters · filed 2016-02-24 | $9.40M derived: sum of 4 quarters · filed 2016-02-24 | ||||
| 2014-03-31 | $2.69M 10-Q · filed 2015-05-08 | $43.39M 10-Q · filed 2014-05-07 | $5.17M derived: sum of 2 quarters · filed 2016-02-24 | $7.27M derived: sum of 3 quarters · filed 2016-02-24 | $9.69M derived: sum of 4 quarters · filed 2016-02-24 | |||
| 2013-12-31 | $2.48M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $4.59M derived: sum of 2 quarters · filed 2016-02-24 | $7.00M derived: sum of 3 quarters · filed 2016-02-24 | $9.04M 10-K · filed 2016-02-24 | $125.18M 10-K · filed 2014-03-03 | |||
| 2013-09-30 | $2.10M 10-Q · filed 2014-11-04 | $33.40M 10-Q · filed 2013-11-01 | $4.52M derived: sum of 2 quarters · filed 2014-11-04 | $6.55M 10-Q · filed 2014-11-04 | $91.55M 10-Q · filed 2013-11-01 | -$50.69M derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2013-06-30 | $2.41M 10-Q · filed 2014-08-07 | $31.74M 10-Q · filed 2013-08-01 | $4.45M 10-Q · filed 2014-08-07 | $58.16M 10-Q · filed 2013-08-01 | -$52.80M derived: sum of 3 quarters · filed 2015-02-27 | -$25.77M derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2013-03-31 | $26.42M 10-Q · filed 2014-05-07 | -$55.21M derived: sum of 2 quarters · filed 2015-02-27 | -$28.18M derived: sum of 3 quarters · filed 2015-02-27 | $1.37M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2012-12-31 | -$81.63M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | -$54.60M derived: sum of 2 quarters · filed 2015-02-27 | -$25.05M derived: sum of 3 quarters · filed 2015-02-27 | $8.15M 10-K · filed 2015-02-27 | $117.90M 10-K · filed 2013-02-26 | |||
| 2012-09-30 | $27.03M 10-Q · filed 2013-11-01 | $56.58M derived: sum of 2 quarters · filed 2013-11-01 | $89.78M 10-Q · filed 2013-11-01 | $122.25M derived: sum of 4 quarters · filed 2014-03-03 | ||||
| 2012-06-30 | $29.55M 10-Q · filed 2013-08-01 | $62.75M 10-Q · filed 2013-08-01 | $95.22M derived: sum of 3 quarters · filed 2014-03-03 | $123.06M derived: sum of 4 quarters · filed 2014-03-03 | ||||
| 2012-03-31 | $33.20M 10-Q · filed 2013-05-01 | $65.67M derived: sum of 2 quarters · filed 2014-03-03 | $93.51M derived: sum of 3 quarters · filed 2014-03-03 | $116.31M derived: sum of 4 quarters · filed 2014-03-03 | ||||
| 2011-12-31 | $32.47M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $60.31M derived: sum of 2 quarters · filed 2014-03-03 | $83.10M derived: sum of 3 quarters · filed 2014-03-03 | $103.57M 10-K · filed 2014-03-03 | ||||
| 2011-09-30 | $27.84M 10-Q · filed 2012-10-31 | $50.63M derived: sum of 2 quarters · filed 2012-10-31 | $71.10M 10-Q · filed 2012-10-31 | $88.58M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-06-30 | $22.80M 10-Q · filed 2012-08-01 | $43.26M 10-Q · filed 2012-08-01 | $60.74M derived: sum of 3 quarters · filed 2013-02-26 | $79.28M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-03-31 | $20.46M 10-Q · filed 2012-05-02 | $37.94M derived: sum of 2 quarters · filed 2013-02-26 | $56.48M derived: sum of 3 quarters · filed 2013-02-26 | $75.18M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2010-12-31 | $17.48M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $36.01M derived: sum of 2 quarters · filed 2013-02-26 | $54.72M derived: sum of 3 quarters · filed 2013-02-26 | $75.07M 10-K · filed 2013-02-26 | ||||
| 2010-09-30 | $18.54M 10-Q · filed 2011-11-02 | $37.24M derived: sum of 2 quarters · filed 2011-11-02 | $57.59M 10-Q · filed 2011-11-02 | |||||
| 2010-06-30 | $18.70M 10-Q · filed 2011-08-03 | $39.06M 10-Q · filed 2011-08-03 | ||||||
| 2009-12-31 | $77.52M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |